Ad6-Based GM-CSF Expressing Vector Displays Oncolytic and Immunostimulatory Effects in an Immunocompetent Syrian Hamster Model of Cholangiocarcinoma.

Summary: Bile duct cancer (cholangiocarcinoma) is notoriously difficult to treat because it often resists standard chemotherapy and radiation. In a search for better options, researchers turned to a specific strain of the common cold virus, known as Adenovirus type 6 (Ad6). Unlike other viral treatments, Ad6 is less likely to be blocked by the body's natural defenses before reaching the tumor. The scientists engineered this virus to carry a special immune-boosting signal called GM-CSF. When tested in hamsters with bile duct cancer, this "smart virus" not only attacked the tumor cells directly but also rallied the immune system’s soldiers (T cells and macrophages) to join the fight. The treatment significantly slowed tumor growth and extended survival without causing toxic side effects, offering a promising new strategy for fighting this aggressive liver cancer.